Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8955 |
High Similarity |
NPD2796 |
Approved |
0.874 |
High Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8409 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8345 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8322 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8309 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8296 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8286 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8244 |
Intermediate Similarity |
NPD3972 |
Approved |
0.8219 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8214 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8201 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8175 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8116 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8085 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8069 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8042 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8041 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8015 |
Intermediate Similarity |
NPD17 |
Approved |
0.8014 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7985 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7947 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7939 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7931 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7881 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7862 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7857 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7838 |
Intermediate Similarity |
NPD920 |
Approved |
0.7836 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7823 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7823 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7794 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7794 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD411 |
Approved |
0.7761 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7761 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7712 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7712 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD919 |
Approved |
0.7664 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7664 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7662 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7562 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7537 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7533 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7519 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6099 |
Approved |
0.75 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7483 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7483 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7467 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7467 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7466 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7413 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7413 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7333 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7313 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD943 |
Approved |
0.729 |
Intermediate Similarity |
NPD5889 |
Approved |
0.729 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7266 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7246 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7186 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7185 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7162 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3869 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD3873 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7123 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7071 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD6385 |
Approved |
0.707 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7063 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD2649 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2651 |
Approved |
0.705 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7045
|
Intermediate Similarity |
NPD5451 |
Approved |